Top Story

Bivalent HPV vaccine immunogenic, safe

August 20, 2014

The HPV-16/18 AS04-adjuvanted vaccine demonstrated efficacy and immunogenicity without any safety concerns, according to recent study results published in Human Vaccines and Immunotherapeutics.

The study was a follow-up of a double blind, randomized, placebo-controlled trial (HPV-001). Researchers assessed the efficacy of a bivalent HPV-16/18 vaccine (Cervarix, GlaxoSmithKline) in a subset of 437 women from the original study enrolled at five Brazilian centers. Participants were aged 15 to 25 years, and had previously been assigned vaccination or placebo. For the current study (HPV-023), researchers followed participants for more than 9 years, taking annual measurements of anti-HPV-16/18 antibodies.

In the JournalsPerspective

Higher BMI increased risk for 10 common cancers

August 13, 2014
Higher BMI increased individuals’ risks for 10 common cancers, according to results of a population-based cohort study conducted in the United Kingdom.More than…
In the JournalsPerspective

H. pylori eradication reduced gastric cancer incidence

July 23, 2014
Helicobacter pylori eradication therapy reduced the incidence of gastric cancer in asymptomatic Asian patients, according to recent study data. “

Top 8 lessons learned at ASCO 2014

June 25, 2014
The theme of this year’s ASCO Annual Meeting, “Science and Society,” emphasized patient-centered focus — looking at the full implications of a…
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
CME
figure

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »

Filter By:

In the Journals

Bivalent HPV vaccine immunogenic, safe

August 20, 2014
The HPV-16/18 AS04-adjuvanted vaccine demonstrated efficacy and immunogenicity without any safety concerns, according to recent study results…
In the Journals Perspective

Higher BMI increased risk for 10 common cancers

August 13, 2014
Higher BMI increased individuals’ risks for 10 common cancers, according to results of a population-based cohort study conducted in the United…
In the Journals Perspective

H. pylori eradication reduced gastric cancer incidence

July 23, 2014
Helicobacter pylori eradication therapy reduced the incidence of gastric cancer in asymptomatic Asian patients, according to recent study data…

Top 8 lessons learned at ASCO 2014

June 25, 2014
The theme of this year’s ASCO Annual Meeting, “Science and Society,” emphasized patient-centered focus — looking at the full…
Meeting News Coverage Perspective

Discontinuation of statin use near end of life improved QOL

May 30, 2014
CHICAGO — Discontinuation of statin therapy in patients with limited life expectancy improved overall quality of life without compromising…

Hookah smoking remains popular among college students despite known risks

May 28, 2014
Two recent studies have highlighted the potential dangers and confusing messaging surrounding hookah pipe smoking, which appears to be particularly…
Meeting News Coverage

No concerning safety patterns for HPV4 during pregnancy

May 7, 2014
BETHESDA, Md. — CDC researchers did not find any “new or unexpected patterns” in maternal or fetal outcomes after exposure to the…
In the Journals Perspective

Brain, neck tumors reported in 3 dozen cath lab operators

April 25, 2014
Data presented at SOLACI-CACI 2014 have found brain and neck tumors among 36 interventional cardiologists, electrophysiologists and interventional…
In the Journals Perspective

Brain, neck tumors reported in 3 dozen cath lab operators

Cardiology Today, June 2014
Data presented at SOLACI-CACI 2014 have found brain and neck tumors among 36 interventional cardiologists, electrophysiologists and interventional…
FDA approvals

FDA approves HPV test for primary cervical cancer

April 24, 2014
The FDA today approved the cobas HPV Test for women aged at least 25 years to be used alone to aid a health care professional assess the need to…
More Headlines »